Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Todd A Hopkins

Showing results (11-20 of 24) with videos related to

Pageof 3
Sort By:
The Journal of Chemical Physics|April 25, 2008
Infrared spectroscopic study of C(2)F(6) monolayers and bilayers on graphiteTodd A Hopkins, David A Boyd, Yu Xia, et al.
Journal of Virology|January 15, 2003
Amino acid changes within conserved region III of the herpes simplex virus and human cytomegalovirus DNA polymerases confer resistance to 4-oxo-dihydroquinolines, a novel class of herpesvirus antiviral agentsDarrell R Thomsen, Nancee L Oien, Todd A Hopkins, et al.
Medchemcomm|July 16, 2019
Controlling cellular distribution of drugs with permeability modifying moietiesPaul L Richardson, Violeta L Marin, Stormy L Koeniger, et al.
Journal of Medicinal Chemistry|September 2, 2005
4-Oxo-4,7-dihydrothieno[2,3-b]pyridines as non-nucleoside inhibitors of human cytomegalovirus and related herpesvirus polymerasesMark E Schnute, Michele M Cudahy, Roger J Brideau, et al.
Bioorganic & Medicinal Chemistry Letters|July 4, 2008
Synthesis of 4-oxo-4,7-dihydrofuro[2,3-b]pyridine-5-carboxamides with broad-spectrum human herpesvirus polymerase inhibitionMark E Schnute, Roger J Brideau, Sarah A Collier, et al.
Antiviral Research|March 13, 2002
Broad-spectrum antiviral activity of PNU-183792, a 4-oxo-dihydroquinoline, against human and animal herpesvirusesRoger J Brideau, Mary L Knechtel, Audris Huang, et al.
Bioorganic & Medicinal Chemistry Letters|February 20, 2010
The design and development of 2-aryl-2-hydroxy ethylamine substituted 1H,7H-pyrido[1,2,3-de]quinoxaline-6-carboxamides as inhibitors of human cytomegalovirus polymeraseSteven P Tanis, Joseph W Strohbach, Timothy T Parker, et al.
Molecular Cancer Research : MCR|November 16, 2018
PARP1 Trapping by PARP Inhibitors Drives Cytotoxicity in Both Cancer Cells and Healthy Bone MarrowTodd A Hopkins, William B Ainsworth, Paul A Ellis, et al.
Bioorganic & Medicinal Chemistry Letters|April 21, 2010
Modifications of C-2 on the pyrroloquinoline template aimed at the development of potent herpesvirus antivirals with improved aqueous solubilityJames A Nieman, Sajiv K Nair, Steven E Heasley, et al.
Molecular Cancer Research : MCR|July 29, 2015
Mechanistic Dissection of PARP1 Trapping and the Impact on In Vivo Tolerability and Efficacy of PARP InhibitorsTodd A Hopkins, Yan Shi, Luis E Rodriguez, et al.
Pageof 3

Showing results (11-20 of 24) with videos related to

Sort By:
Pageof 3
The Journal of Chemical Physics|April 25, 2008
Infrared spectroscopic study of C(2)F(6) monolayers and bilayers on graphiteTodd A Hopkins, David A Boyd, Yu Xia, et al.
Journal of Virology|January 15, 2003
Amino acid changes within conserved region III of the herpes simplex virus and human cytomegalovirus DNA polymerases confer resistance to 4-oxo-dihydroquinolines, a novel class of herpesvirus antiviral agentsDarrell R Thomsen, Nancee L Oien, Todd A Hopkins, et al.
Medchemcomm|July 16, 2019
Controlling cellular distribution of drugs with permeability modifying moietiesPaul L Richardson, Violeta L Marin, Stormy L Koeniger, et al.
Journal of Medicinal Chemistry|September 2, 2005
4-Oxo-4,7-dihydrothieno[2,3-b]pyridines as non-nucleoside inhibitors of human cytomegalovirus and related herpesvirus polymerasesMark E Schnute, Michele M Cudahy, Roger J Brideau, et al.
Bioorganic & Medicinal Chemistry Letters|July 4, 2008
Synthesis of 4-oxo-4,7-dihydrofuro[2,3-b]pyridine-5-carboxamides with broad-spectrum human herpesvirus polymerase inhibitionMark E Schnute, Roger J Brideau, Sarah A Collier, et al.
Antiviral Research|March 13, 2002
Broad-spectrum antiviral activity of PNU-183792, a 4-oxo-dihydroquinoline, against human and animal herpesvirusesRoger J Brideau, Mary L Knechtel, Audris Huang, et al.
Bioorganic & Medicinal Chemistry Letters|February 20, 2010
The design and development of 2-aryl-2-hydroxy ethylamine substituted 1H,7H-pyrido[1,2,3-de]quinoxaline-6-carboxamides as inhibitors of human cytomegalovirus polymeraseSteven P Tanis, Joseph W Strohbach, Timothy T Parker, et al.
Molecular Cancer Research : MCR|November 16, 2018
PARP1 Trapping by PARP Inhibitors Drives Cytotoxicity in Both Cancer Cells and Healthy Bone MarrowTodd A Hopkins, William B Ainsworth, Paul A Ellis, et al.
Bioorganic & Medicinal Chemistry Letters|April 21, 2010
Modifications of C-2 on the pyrroloquinoline template aimed at the development of potent herpesvirus antivirals with improved aqueous solubilityJames A Nieman, Sajiv K Nair, Steven E Heasley, et al.
Molecular Cancer Research : MCR|July 29, 2015
Mechanistic Dissection of PARP1 Trapping and the Impact on In Vivo Tolerability and Efficacy of PARP InhibitorsTodd A Hopkins, Yan Shi, Luis E Rodriguez, et al.
Pageof 3